Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a ...

A new randomized clinical trial showed that receiving immunochemotherapy infusions earlier in the day may help patients with ...

Researchers are testing whether fecal microbiota transplants can reduce side effects and boost cancer treatment response.

A curious phenomenon seen by oncologists, that morning patients do better than those receiving afternoon infusions, gains ...

A UCLA research team has identified the best design for a promising new type of immunotherapy that could be mass-produced to ...

By analyzing tissue from patients with Parkinson's disease, and animal and cellular models of the disease, a research team ...

Researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy have ...

Cancer immunotherapy has been a game-changer, but many tumors still find ways to slip past the immune system. New research ...

Long-term clinical trials show patients with stage four kidney cancer are living a decade or more beyond previous ...

Pembrolizumab works by blocking a mechanism that cancer cells use to evade detection by the immune system, according to Drugs ...

The landscape of triple-negative breast cancer (TNBC) is shifting rapidly. What was once a landscape dominated by standard cytotoxic chemotherapy is now a complex map of immunotherapy, PARP inhibitors ...